focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLAN.L Regulatory News (GLAN)

  • There is currently no data for GLAN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Glantus Holdings plc

18 Aug 2023 13:01

RNS Number : 8177J
Amati Global Investors Ltd
18 August 2023
 

Ap27

 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Amati Global Investors Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

Glantus Holdings PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

N/A

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

18 August 2023

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

If YES, specify which:

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

 

Ap28

 

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

(Note 2)

 

Class of relevant security (Note 3)

Ordinary Shares of €0.001 each

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

2,941,176

5.75%

(2) Cash-settled derivatives

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

Total

2,941,176

5.75%

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

 

Ap29

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

 

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

 

 

 

 

 

Ap30

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 None

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

NO

 

Date of disclosure

18 August 2023

Contact name

Andrew Lynn

Telephone number

+441315039105

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

Ap31

 

NOTES ON FORM 8.3

 

1. See the definition of "connected fund manager" in Rule 2.2 of Part A of the Rules.

 

2. See the definition of "interest in a relevant security" in Rule 2.5 of Part A of the Rules and see Rule 8.6(a) and (b) of Part B of the Rules.

 

3. See the definition of "relevant securities" in Rule 2.1 of Part A of the Rules.

 

4. See the definition of "dealing" in Rule 2.1 of Part A of the Rules.

 

5. If the economic exposure to changes in the price of securities is limited, for example, by virtue of a stop loss arrangement relating to a spread bet, full details must be given.

 

6. See Rule 2.5(d) of Part A of the Rules.

 

7. If details included in a disclosure under Rule 8 are incorrect, they should be corrected as soon as practicable in a subsequent disclosure. Such disclosure should state clearly that it corrects details disclosed previously, identify the disclosure or disclosures being corrected, and provide sufficient detail for the reader to understand the nature of the corrections. In the case of any doubt, the Panel should be consulted.

 

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

 

References in these notes to "the Rules" are to the Irish Takeover Panel Act, 1997, Takeover Rules, 2022.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPUWVAROBUWAAR
Date   Source Headline
21st Jul 20238:29 amGNWForm 8.5 (EPT/RI) - Glantus Holdings Plc
19th Jul 20238:25 amGNWForm 8.5 (EPT/RI) - Glantus Holdings Plc
18th Jul 20238:00 amGNWForm 8.5 (EPT/RI) - Glantus Holdings Plc
17th Jul 20237:57 amGNWForm 8.5 (EPT/RI) - Glantus Holdings Plc
14th Jul 20234:08 pmRNSForm 8.3 - Glantus Holdings plc
14th Jul 20239:50 amRNSForm 8.3 - Glantus Holdings plc
14th Jul 20238:29 amGNWForm 8.5 (EPT/RI) - Glantus Holdings Plc
13th Jul 20232:04 pmRNSForm 8.3/Form 38.5(a) – Glantus Holdings plc
12th Jul 20233:00 pmRNSForm 8.3 - Glantus Holdings plc
12th Jul 202312:03 pmRNSForm 8.3 - Glantus Holdings plc
12th Jul 20239:42 amRNSForm 8.3 - Glantus Holdings Plc
12th Jul 20238:23 amGNWForm 8.5 (EPT/RI) - Glantus Holdings PLC
10th Jul 20236:05 pmRNSForm 8.3 - Glantus Holdings plc
10th Jul 20236:00 pmRNSForm 8.3 - Glantus Holdings plc
10th Jul 20234:22 pmRNSHolding(s) in Company
10th Jul 20233:18 pmGNWForm 8.3 - Octopus Investments - Glantus Holdings plc
10th Jul 20239:27 amGNWForm 8.5 (EPT/RI) - Glantus Holdings PLC
7th Jul 20235:17 pmRNSForm 8.3 - Glantus Holdings plc
7th Jul 20231:55 pmRNSForm 8.1
7th Jul 20238:52 amGNWForm 8.5 (EPT/RI)
6th Jul 202312:59 pmGNWForm 8.3 - Octopus Investments - Glantus Holdings plc
6th Jul 202312:12 pmGNWForm 8.5 (EPT/RI) - Glantus Holdings Plc
5th Jul 202310:41 amRNSStatement regarding recent share price movement
30th Jun 20237:00 amRNSFull Year Results & Availability of Annual Report
16th May 20237:00 amRNSQ1 2023 Trading Update and Directorate Change
31st Mar 202311:51 amRNSDirector Shareholding
21st Mar 20233:23 pmRNSHolding(s) in Company
21st Mar 20232:52 pmRNSHolding(s) in Company
16th Mar 20231:28 pmRNSResult of Extraordinary General Meeting and TVR
13th Mar 20237:00 amRNSSilicon Valley Bank
20th Feb 20234:00 pmRNSDirector Shareholding
17th Feb 20237:00 amRNSPublication of Circular and Notice of GM
14th Feb 20234:40 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20234:31 pmRNSConditional Subscription for new shares
14th Feb 20237:00 amRNSFY 2022 Trading Update
14th Dec 20227:00 amRNSRepayment of Short Term Working Capital Facility
9th Dec 20227:00 amRNSDirectorate Change
5th Dec 20221:50 pmRNSUpdate re. Completion of Software Sale
24th Oct 20227:00 amRNSAdditional Working Capital Facility
11th Oct 20223:02 pmRNSSale of Software to Customer
29th Sep 20227:00 amRNSDirector Shareholding
28th Sep 20224:41 pmRNSSecond Price Monitoring Extn
28th Sep 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20222:05 pmRNSSecond Price Monitoring Extn
28th Sep 20222:00 pmRNSPrice Monitoring Extension
28th Sep 202211:06 amRNSSecond Price Monitoring Extn
28th Sep 202211:00 amRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSInterim Results
4th Aug 202212:13 pmRNSResults of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.